PharmiWeb.com - Global Pharma News & Resources
06-Aug-2018

Creative Biolabs Launches Magicâ„¢ Therapeutic Antibody Discovery Service

As a forerunner and innovator in antibody discovery and production, Creative Biolabs currently provides you with Magic™ Therapeutic Antibody Discovery Platform (MTADP) in order to help attain high affinity antibodies from immunized animals efficiently.

To get substantial antibody candidates serves as the most initial step in obtaining high-quality antibodies with all required properties and also the only approach to attaining them, burdening the researchers with a tough task to produce diagnostic and therapeutic antibody. In addition, according to the empirical research, a good antibody[pair] can only be discovered from more than a hundred regular binders raised utilizing distinct measures in different animals. Thus, the properties and sequences turn out to be extremely various.

As you may agree, it is quite inefficient to finish this project employing the conventional way of hybridoma technology, and it may also baffle you due to its high cost. Auspiciously, Creative Biolabs has addressed your trouble. As a high-throughput and an accurate antibody generation approach, MTADP targets for therapeutic antibody development with unsurpassed manufacturability. Its efficiency deserves the primary benefit to be mentioned. MTADP is much more time-saving for functional therapeutic antibody development, compared with the previous method which only provides several unique antibody sequences for the unique target.

"Antibody candidates for the target can be separated at one time with a surprising number of 105-7." said one of the researchers of Creative Biolabs. More specifically, up to 300 unique high specific antibodies with affinities (KD) can be discovered by this platform in the sub 10 pM range against the target, combined with their cutting-edged libraries sequencing pre-made human antibodies and library screening services.

Besides, problem-solving ability of MTADP also deserves to be mentioned. Prefigured by the researchers of Creative Biolabs on the potential problems of antibody drug development, such as asparagine deamidation, MTADP can settle them with exceeding performance.

"Our Magic™ Therapeutic Antibody Discovery has contributed a lot with respect to antibody discovery, considered by most experts as a highly advanced technology with high purity, broad applications and low off-target activity." said the manager of Creative Biolabs.

The advantages of MTADP are not limited to those mentioned above. Creative Biolabs has undoubtedly broken through the tradition and promises to provide the best service for you.

About us

Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields. Our service portfolio includes mouse and rat monoclonal antibody production using hybridoma technology, human, monkey, rabbit, chicken, dog, llama and camel monoclonal antibody production using various antibody library technologies (including phage display, bacterial display and yeast display). We are also professional in conducting in depth antibody humanization and affinity maturation using phage display and DNA mutagenesis approaches. In addition, OEM services for bulk scale antibody manufacturing, including bacterial production of scFv, diabody, tandem scFv, miniantibody and Fab, and mammalian cell expression of minibody, chimeric IgG and IgG, are also available at the most competitive price in the industry.

Editor Details

Last Updated: 06-Aug-2018